secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2022-08-10T23:59:59+00:00
Accession:  0001193125-22-217452
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya Therapeutics enters $75M at-the-market equity sales agreement with SVB Securities
--------------------------------------------------------------------------------

- Aggregate sales proceeds up to $75M from common stock sold through ATM program.
- SVB Securities receives 3.0% commission on gross proceeds as sales agent.
- Company sets parameters including price and volume; no obligation to sell shares.
- Shares issued under shelf registration statement filed August 10, 2022.
- Agreement can be terminated by either party on 10 days' notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000119312522217452/0001193125-22-217452-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000119312522217452/d301698d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-217452

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer